Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ANDA Pre-Submission Meetings A 'Challenge' To Integrate Into Development Timelines

Feb 23 2018

• By Derrick Gingery

FDA entrance sign 2016

Related Content

Unhappy With GDUFA II? Note It For GDUFA III, FDA Says

Nov 28 2017

FDA Met Biosimilar Review Timelines But Missed Meeting Goals In 2015

Apr 25 2016

FDA Web Portal Eases Pre-ANDA Meeting Request Process

Oct 10 2017

Complex ANDAs: Early Meetings With FDA Can Generate Bonus Communication

Oct 03 2017

US FDA Commits To Meeting With Complex ANDA Sponsors, Works Hard To Avoid It

Oct 24 2017

Biosimilars Will Get PDUFA-Style Reviews Under New User Fee Plan

Sep 28 2016

Sponsors, FDA Reviewers To Get More Flexibility Under New User Fee Program

Jul 16 2016

Complex ANDAs To Be Allowed Pre-Submission Product Meetings

Oct 24 2016

Additional Topics

United States Generic Drugs Review Pathway Regulation FDA BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window